AR109846A1 - Validación de aclaramiento viral continuo - Google Patents

Validación de aclaramiento viral continuo

Info

Publication number
AR109846A1
AR109846A1 ARP170102921A ARP170102921A AR109846A1 AR 109846 A1 AR109846 A1 AR 109846A1 AR P170102921 A ARP170102921 A AR P170102921A AR P170102921 A ARP170102921 A AR P170102921A AR 109846 A1 AR109846 A1 AR 109846A1
Authority
AR
Argentina
Prior art keywords
validation
viral clearance
probe
continuous viral
continuous
Prior art date
Application number
ARP170102921A
Other languages
English (en)
Spanish (es)
Inventor
Lobedann Martin Dr
Laura Holtmann
Schwan Peter Dr
Maiser Benjamin Dr
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of AR109846A1 publication Critical patent/AR109846A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/22Testing for sterility conditions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08Radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/16Disinfection or sterilisation of materials or objects, in general; Accessories therefor using chemical substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05Living organisms or biological materials
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ARP170102921A 2016-10-21 2017-10-20 Validación de aclaramiento viral continuo AR109846A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16194959.9A EP3141611A3 (en) 2016-10-21 2016-10-21 Validation of continuous viral clearance

Publications (1)

Publication Number Publication Date
AR109846A1 true AR109846A1 (es) 2019-01-30

Family

ID=57209212

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170102921A AR109846A1 (es) 2016-10-21 2017-10-20 Validación de aclaramiento viral continuo

Country Status (16)

Country Link
US (1) US10894991B2 (https=)
EP (2) EP3141611A3 (https=)
JP (1) JP2019537435A (https=)
KR (1) KR20190066017A (https=)
CN (1) CN110100008A (https=)
AR (1) AR109846A1 (https=)
AU (1) AU2017345412A1 (https=)
BR (1) BR112019007835A2 (https=)
CA (1) CA3041253A1 (https=)
IL (1) IL266095A (https=)
MX (1) MX385466B (https=)
RU (1) RU2755634C2 (https=)
SG (1) SG10202104023QA (https=)
TW (1) TW201827830A (https=)
UY (1) UY37447A (https=)
WO (1) WO2018075716A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190022654A1 (en) * 2017-07-10 2019-01-24 Baxalta Incorporated Method for incubating liquids
JP7390466B2 (ja) * 2020-02-28 2023-12-01 旭化成メディカル株式会社 ウイルスクリアランス性能の評価方法
CA3195893A1 (en) * 2020-09-21 2022-03-24 Bayer Healthcare Llc Pathogen clearance system and method
US12203914B2 (en) * 2020-11-12 2025-01-21 Sartorius Bioanalytical Instruments, Inc. Viral clearance evaluation for biological medical product preparation processes
WO2022203044A1 (ja) * 2021-03-26 2022-09-29 旭化成メディカル株式会社 ウイルスクリアランス試験の方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9644187B2 (en) * 2010-04-14 2017-05-09 Emd Millipore Corporation Methods of producing high titer, high purity virus stocks and methods of use thereof
AU2014100888A4 (en) * 2014-08-07 2014-09-11 Novartis Ag Virus clearance and protein purification methods

Also Published As

Publication number Publication date
TW201827830A (zh) 2018-08-01
WO2018075716A1 (en) 2018-04-26
MX385466B (es) 2025-03-18
EP3141611A3 (en) 2017-05-10
BR112019007835A2 (pt) 2019-10-01
SG10202104023QA (en) 2021-06-29
KR20190066017A (ko) 2019-06-12
IL266095A (en) 2019-06-30
US20190316213A1 (en) 2019-10-17
EP3141611A2 (en) 2017-03-15
AU2017345412A1 (en) 2019-04-18
RU2755634C2 (ru) 2021-09-17
RU2019115375A3 (https=) 2021-03-19
EP3529367A1 (en) 2019-08-28
US10894991B2 (en) 2021-01-19
UY37447A (es) 2018-05-31
JP2019537435A (ja) 2019-12-26
MX2019004540A (es) 2019-06-12
CN110100008A (zh) 2019-08-06
CA3041253A1 (en) 2018-04-26
RU2019115375A (ru) 2020-11-23

Similar Documents

Publication Publication Date Title
AR109846A1 (es) Validación de aclaramiento viral continuo
CL2019000278A1 (es) Agentes rnai para infección con virus de hepatitis b.
IL280559A (en) Hepatitis b virus (hbv) dsrna agent compositions and methods of use thereof
IL279706A (en) Scanning electron microscope and methods of inspecting and reviewing samples
CL2014002551A1 (es) Metodo para identificar segmento de audio, que comprende las etapas de crear un espectrograma del segmento candidato de audio, crear un mapa candidato de bits huella digital y acustica del espectrograma, comparar el mapa candidato con al menos un mapa conocido de un mensaje de red conocido, si el mapa candidato coincide con un mapa conocido, declarar el calce, y si el candidato no coincide, utilizar un algoritmo de deteccion para analizar el segmento de audio candidato; metodos asociados.
IL256644B (en) System and method for management, execution, and analysis of laboratory experiments
CO2017003490A2 (es) Moléculas de anticuerpos a pd-l1
CL2018001156A1 (es) Preparación de muestras para muestras difíciles.
DK3643795T3 (da) Fremganffremgangsmåde til bestemmelse af celle- eller vævsdød ved analyse af dna-methylering
IL248104B (en) Defect sampling for electron beam review based on defect attributes from optical inspection and optical review
DK3224755T3 (da) Statistisk analysefremgangsmåde til bestemmelse af risiko ved filbaseret indhold
MA52506A (fr) Procédés de traitement d'infections par des virus nipah
MX2015012437A (es) Esteroides neuroactivos, composiciones, y usos de los mismos.
DK3194612T3 (da) Fremgangsmåder til kvantitativ genetisk analyse af cellefrit dna
IL271147A (en) Methods for accurate computational decomposition of dna mixtures from contributors of unknown genotypes
EP3414650A4 (en) SOCIAL KEYBOARD
MX2017005888A (es) Dispositivos, sistemas y metodos para la deteccion de analitos.
PE20180171A1 (es) Neutralizacion del virus chikungunya mediada por anticuerpos
EP3630732A4 (en) Method and molecules
MX2016013877A (es) Composiciones y metodos para mejorar y/o predecir la amplificacion de adn.
MX2017003635A (es) Metodo para medir la reactividad del factor de coagulacion viii (fviii).
Guo et al. A systematic method for analyzing robust stability of interval neural networks with time-delays based on stability criteria
NI201600147A (es) Métodos y aparato para la coordinación de la selección del sistema entre un conjunto de nodos
DK3201635T3 (da) Metode til forudsigelse af progression af kræft ved nanomekanisk profilering
BR112018008757A2 (pt) suspensor de liner

Legal Events

Date Code Title Description
FA Abandonment or withdrawal